Old Web
English
Sign In
Acemap
>
authorDetail
>
Kota Vidyasagar
Kota Vidyasagar
Medicine
Internal medicine
Randomized controlled trial
Odds ratio
Polypharmacy
5
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The safety, tolerability and mortality reduction efficacy of remdesivir;based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis
2021
Therapeutic advances in drug safety
C Santenna
Kota Vidyasagar
Krishna Chaitanya Amarneni
Sai Nikhila Ghanta
Balakrishnan Sadasivam
Saman Pathan
R. Padmavathi
Show All
Source
Cite
Save
Citations (0)
Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis
2021
Frontiers in Pharmacology
Akshaya Srikanth Bhagavathula
Kota Vidyasagar
Manik Chhabra
Muhammed Rashid
Rishabh Sharma
Deepak Kumar Bandari
Daniela Fialová
Show All
Source
Cite
Save
Citations (1)
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials
2021
Pharmaceuticals
Akshaya Srikanth Bhagavathula
Kota Vidyasagar
Wubshet Tesfaye
Show All
Source
Cite
Save
Citations (0)
Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: a Bayesian Indirect Treatment Comparison
2020
Clinical Therapeutics
Kota Vidyasagar
Boya Chandrasekar
Manik Chhabra
Anil Bhansali
Dipika Bansal
Show All
Source
Cite
Save
Citations (2)
Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-Sectional Study.
2020
R. D. Sharma
Manik Chhabra
Kota Vidyasagar
Muhammed Rashid
Daniela Fialová
Akshaya S. Bhagavathula
Show All
Source
Cite
Save
Citations (4)
1